Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02722694
What this trial is testing

Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis (RA)
Jiangsu Simcere Pharmaceutical Co., Ltd. 360
Early research (Phase 1)Study completedNCT01751776
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy

Who this might be right for
Arthritis, RheumatoidHealthy
Boehringer Ingelheim 107
Post-approval studies (Phase 4)Ended earlyNCT06773455
What this trial is testing

Tralokinumab for Dupilumab Failures

Who this might be right for
Atopic Dermatitis
Psoriasis Treatment Center of Central New Jersey 7
Post-approval studies (Phase 4)Study completedNCT03505008
What this trial is testing

Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan

Who this might be right for
Rheumatoid Arthritis
Keio University 300
Large-scale testing (Phase 3)Study completedNCT01272908
What this trial is testing

MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 120
Testing effectiveness (Phase 2)Ended earlyNCT03742973
What this trial is testing

Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA

Who this might be right for
Primary Biliary Cholangitis
Eli Lilly and Company 2
Not applicableStudy completedNCT02109939
What this trial is testing

Genomics Used to Improve DEpression Decisions

Who this might be right for
Major Depressive Disorder (MDD)
Assurex Health Inc. 1,398
Large-scale testing (Phase 3)Study completedNCT00810277
What this trial is testing

Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 14
Large-scale testing (Phase 3)Study completedNCT02046603
What this trial is testing

Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 162
Testing effectiveness (Phase 2)Ended earlyNCT03001219
What this trial is testing

RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 109
Large-scale testing (Phase 3)Study completedNCT02873936
What this trial is testing

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 449
Not applicableStudy completedNCT01641952
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 505
Large-scale testing (Phase 3)Study completedNCT02001987
What this trial is testing

Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 139
Large-scale testing (Phase 3)Study completedNCT01180400
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 295
Large-scale testing (Phase 3)Study completedNCT01197534
What this trial is testing

Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 913
Post-approval studies (Phase 4)Study completedNCT01077375
What this trial is testing

Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia

Who this might be right for
Fibromyalgia
Forest Laboratories 107
Large-scale testing (Phase 3)Study completedNCT00106574
What this trial is testing

Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,220
Post-approval studies (Phase 4)Study completedNCT00462345
What this trial is testing

MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 40
Large-scale testing (Phase 3)Study completedNCT01610791
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 121
Large-scale testing (Phase 3)Study completedNCT00124982
What this trial is testing

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,286
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation